Cefadroxil
- Product NDC
- 10544-135
- 11-digit product format
- 105440135
- Labeler code
- 10544
- Product ID
- 10544-135_11e2a86f-0d12-4eda-8472-9b94efe2ef58
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefadroxil
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Blenheim Pharmacal, Inc.
- Application
- ANDA065392
- Marketing category
- ANDA
- Marketing start
- 2011-07-11
- Marketing end
- 0000-00-00
- Substance
- CEFADROXIL
- Active strength
- 500 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10544-135-20 | Cefadroxil | 50 in 1 BOTTLE | CAPSULE | 50 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CEFADROXIL | ACTIVE INGREDIENT | 280111G160 | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| CEFADROXIL ANHYDROUS | ACTIVE MOIETY | Q525PA8JJB | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| D&C RED NO. 28 | INACTIVE INGREDIENT | 767IP0Y5NH | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10544-135 | CEFADROXIL CAPSULE [BLENHEIM PHARMACAL, INC.] | 2 | Legacy NDC, 1 package rows | 20151111_615617a6-40b9-46e2-9a3d-169ea5a671de.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 10544-135-20 | 10544013520 | 50 in 1 BOTTLE | Historical |